{"pmid":32362647,"title":"Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020.","text":["Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020.","Background & objectives: Sentinel surveillance among severe acute respiratory illness (SARI) patients can help identify the spread and extent of transmission of coronavirus disease 2019 (COVID-19). SARI surveillance was initiated in the early phase of the COVID-19 outbreak in India. We describe here the positivity for COVID-19 among SARI patients and their characteristics. Methods: SARI patients admitted at 41 sentinel sites from February 15, 2020 onwards were tested for COVID-19 by real-time reverse transcription-polymerase chain reaction, targeting E and RdRp genes of SARS-CoV-2. Data were extracted from Virus Research and Diagnostic Laboratory Network for analysis. Results: A total of 104 (1.8%) of the 5,911 SARI patients tested were positive for COVID-19. These cases were reported from 52 districts in 20 States/Union Territories. The COVID-19 positivity was higher among males and patients aged above 50 years. In all, 40 (39.2%) COVID-19 cases did not report any history of contact with a known case or international travel. Interpretation & conclusions: COVID-19 containment activities need to be targeted in districts reporting COVID-19 cases among SARI patients. Intensifying sentinel surveillance for COVID-19 among SARI patients may be an efficient tool to effectively use resources towards containment and mitigation efforts.","Indian J Med Res","Gupta, Nivedita","Praharaj, Ira","Bhatnagar, Tarun","Vivian Thangaraj, Jeromie Wesley","Giri, Sidhartha","Chauhan, Himanshu","Kulkarni, Sanket","Murhekar, Manoj","Singh, Sujeet","Gangakhedkar, Raman R","Bhargava, Balram","32362647"],"abstract":["Background & objectives: Sentinel surveillance among severe acute respiratory illness (SARI) patients can help identify the spread and extent of transmission of coronavirus disease 2019 (COVID-19). SARI surveillance was initiated in the early phase of the COVID-19 outbreak in India. We describe here the positivity for COVID-19 among SARI patients and their characteristics. Methods: SARI patients admitted at 41 sentinel sites from February 15, 2020 onwards were tested for COVID-19 by real-time reverse transcription-polymerase chain reaction, targeting E and RdRp genes of SARS-CoV-2. Data were extracted from Virus Research and Diagnostic Laboratory Network for analysis. Results: A total of 104 (1.8%) of the 5,911 SARI patients tested were positive for COVID-19. These cases were reported from 52 districts in 20 States/Union Territories. The COVID-19 positivity was higher among males and patients aged above 50 years. In all, 40 (39.2%) COVID-19 cases did not report any history of contact with a known case or international travel. Interpretation & conclusions: COVID-19 containment activities need to be targeted in districts reporting COVID-19 cases among SARI patients. Intensifying sentinel surveillance for COVID-19 among SARI patients may be an efficient tool to effectively use resources towards containment and mitigation efforts."],"journal":"Indian J Med Res","authors":["Gupta, Nivedita","Praharaj, Ira","Bhatnagar, Tarun","Vivian Thangaraj, Jeromie Wesley","Giri, Sidhartha","Chauhan, Himanshu","Kulkarni, Sanket","Murhekar, Manoj","Singh, Sujeet","Gangakhedkar, Raman R","Bhargava, Balram"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32362647","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.4103/ijmr.IJMR_1035_20","keywords":[" covid-19"," sari"," sentinel"," surveillance","containment"],"locations":["India","India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666138495966511105,"score":9.490897,"similar":[{"pmid":32321075,"title":"COVID-19 and hospitalizations for SARI in Brazil: a comparison up to the 12th epidemiological week of 2020.","text":["COVID-19 and hospitalizations for SARI in Brazil: a comparison up to the 12th epidemiological week of 2020.","Surveillance of the severe acute respiratory illness (SARI) in Brazil aims to characterize the circulation of the Influenza A and B viruses in hospitalized cases and deaths, having been expanded in 2012 to include other respiratory viruses. COVID-19 was detected in Brazil for the time in the 9th epidemiological week of 2020, and the test for the SARS-CoV-2 virus was included in the surveillance protocol starting in the 12th epidemiological week. This study's objective was to investigate the pattern of hospitalizations for SARI in Brazil since the entry of SARS-CoV-2, comparing the temporal and age profiles and laboratory results to the years 2010 through 2019. In 2020, hospitalizations for SARI, compiled from the date of the first confirmed case of COVID-19 up to the 12th week, exceeded the numbers observed during the same period in each of the previous 10 years. The age bracket over 60 years was the most heavily affected, at higher than historical levels. There was a considerable increase in negative laboratory tests, suggesting circulation of a different virus from those already present in the panel. We concluded that the increase in hospitalizations for SARI, the lack of specific information on the etiological agent, and the predominance of cases among the elderly during the same period in which there was an increase in the number of new cases of COVID-19 are all consistent with the hypothesis that severe cases of COVID-19 are already being detected by SARI surveillance, placing an overload on the health system. The inclusion of testing for SARS-CoV-2 in the SARI surveillance protocol and the test's effective nationwide deployment are extremely important for monitoring the evolution of severe COVID-19 cases in Brazil.","Cad Saude Publica","Bastos, Leonardo Soares","Niquini, Roberta Pereira","Lana, Raquel Martins","Villela, Daniel A M","Cruz, Oswaldo G","Coelho, Flavio C","Codeco, Claudia T","Gomes, Marcelo F C","32321075"],"abstract":["Surveillance of the severe acute respiratory illness (SARI) in Brazil aims to characterize the circulation of the Influenza A and B viruses in hospitalized cases and deaths, having been expanded in 2012 to include other respiratory viruses. COVID-19 was detected in Brazil for the time in the 9th epidemiological week of 2020, and the test for the SARS-CoV-2 virus was included in the surveillance protocol starting in the 12th epidemiological week. This study's objective was to investigate the pattern of hospitalizations for SARI in Brazil since the entry of SARS-CoV-2, comparing the temporal and age profiles and laboratory results to the years 2010 through 2019. In 2020, hospitalizations for SARI, compiled from the date of the first confirmed case of COVID-19 up to the 12th week, exceeded the numbers observed during the same period in each of the previous 10 years. The age bracket over 60 years was the most heavily affected, at higher than historical levels. There was a considerable increase in negative laboratory tests, suggesting circulation of a different virus from those already present in the panel. We concluded that the increase in hospitalizations for SARI, the lack of specific information on the etiological agent, and the predominance of cases among the elderly during the same period in which there was an increase in the number of new cases of COVID-19 are all consistent with the hypothesis that severe cases of COVID-19 are already being detected by SARI surveillance, placing an overload on the health system. The inclusion of testing for SARS-CoV-2 in the SARI surveillance protocol and the test's effective nationwide deployment are extremely important for monitoring the evolution of severe COVID-19 cases in Brazil."],"journal":"Cad Saude Publica","authors":["Bastos, Leonardo Soares","Niquini, Roberta Pereira","Lana, Raquel Martins","Villela, Daniel A M","Cruz, Oswaldo G","Coelho, Flavio C","Codeco, Claudia T","Gomes, Marcelo F C"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32321075","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1590/0102-311X00070120","locations":["Brazil","Brazil","Brazil","Brazil","Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"topics":["Prevention"],"weight":1,"_version_":1666138493648109568,"score":421.9931},{"pmid":32396550,"title":"Virus detections among patients with severe acute respiratory illness, Northern Vietnam.","text":["Virus detections among patients with severe acute respiratory illness, Northern Vietnam.","Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017-2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2-3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7-22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics.","PLoS One","Le, Yen H","Nguyen, Khanh C","Coleman, Kristen K","Nguyen, Tham T","Than, Son T","Phan, Hai H","Nguyen, Manh D","Ngu, Nghia D","Phan, Dan T","Hoang, Phuong V M","Trieu, Long P","Bailey, Emily S","Warkentien, Tyler E","Gray, Gregory C","32396550"],"abstract":["Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017-2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2-3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7-22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics."],"journal":"PLoS One","authors":["Le, Yen H","Nguyen, Khanh C","Coleman, Kristen K","Nguyen, Tham T","Than, Son T","Phan, Hai H","Nguyen, Manh D","Ngu, Nghia D","Phan, Dan T","Hoang, Phuong V M","Trieu, Long P","Bailey, Emily S","Warkentien, Tyler E","Gray, Gregory C"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396550","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1371/journal.pone.0233117","locations":["Vietnam","Hanoi","Hanoi","Vietnam","Singapore"],"countries":["Singapore","Viet Nam"],"countries_codes":["SGP|Singapore","VNM|Viet Nam"],"topics":["Diagnosis"],"weight":1,"_version_":1666627828075986944,"score":396.76758},{"pmid":32445776,"title":"PREVENTION AND PROTECTION MEASURES OF HEALTHCARE WORKERS EXPOSED IN HEALTH SETTINGS TO SEVERE ACUTE RESPIRATORY INFECTIONS FROM SARS-COV-2 IN A UNIVERSITY HOSPITAL IN BARI, APULIA REGION, SOUTHERN ITALY.","text":["PREVENTION AND PROTECTION MEASURES OF HEALTHCARE WORKERS EXPOSED IN HEALTH SETTINGS TO SEVERE ACUTE RESPIRATORY INFECTIONS FROM SARS-COV-2 IN A UNIVERSITY HOSPITAL IN BARI, APULIA REGION, SOUTHERN ITALY.","SARS-CoV-2-related SARIs (severe acute respiratory infections) have a major impact on public health; moreover, healthcare workers (HCWs) are exposed to a high biological risk. The aim of this study was to show the prevention procedures in place in the University Hospital of Bari (Apulia Region, Southern Italy) to reduce this risk to HCWs, consisting of the enhancement of preventive measures and the activation of a report system to collect HCWs' contacts. To date, 23 confirmed cases of infections (0.4% of all HCWs) have been reported in a 30-day observation period. These results show that correct management of HCWs' contacts is essential to avoid nosocomial clusters.","J Hosp Infect","Luigi, Vimercati","Alessandro, Dell'Erba","Giovanni, Migliore","Luigi, De Maria","Antonio, Caputi","Marco, Quarato","Pasquale, Stefanizzi","Domenica, Cavone","Davide, Ferorelli","Stefania, Sponselli","Francesca, Mansi","Silvio, Tafuri","32445776"],"abstract":["SARS-CoV-2-related SARIs (severe acute respiratory infections) have a major impact on public health; moreover, healthcare workers (HCWs) are exposed to a high biological risk. The aim of this study was to show the prevention procedures in place in the University Hospital of Bari (Apulia Region, Southern Italy) to reduce this risk to HCWs, consisting of the enhancement of preventive measures and the activation of a report system to collect HCWs' contacts. To date, 23 confirmed cases of infections (0.4% of all HCWs) have been reported in a 30-day observation period. These results show that correct management of HCWs' contacts is essential to avoid nosocomial clusters."],"journal":"J Hosp Infect","authors":["Luigi, Vimercati","Alessandro, Dell'Erba","Giovanni, Migliore","Luigi, De Maria","Antonio, Caputi","Marco, Quarato","Pasquale, Stefanizzi","Domenica, Cavone","Davide, Ferorelli","Stefania, Sponselli","Francesca, Mansi","Silvio, Tafuri"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445776","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jhin.2020.05.024","keywords":["covid-19","saris","sars-cov-2","healthcare workers","operating procedure","report system"],"locations":["BARI","APULIA REGION"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667600475959066624,"score":262.2828},{"pmid":32271724,"pmcid":"PMC7147906","title":"Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.","text":["Rapid Sentinel Surveillance for COVID-19 - Santa Clara County, California, March 2020.","On February 27, 2020, the Santa Clara County Public Health Department (SCCPHD) identified its first case of coronavirus disease 2019 (COVID-19) associated with probable community transmission (i.e., infection among persons without a known exposure by travel or close contact with a patient with confirmed COVID-19). At the time the investigation began, testing guidance recommended focusing on persons with clinical findings of lower respiratory illness and travel to an affected area or an epidemiologic link to a laboratory-confirmed COVID-19 case, or on persons hospitalized for severe respiratory disease and no alternative diagnosis (1). To rapidly understand the extent of COVID-19 in the community, SCCPHD, the California Department of Public Health (CDPH), and CDC began sentinel surveillance in Santa Clara County. During March 5-14, 2020, four urgent care centers in Santa Clara County participated as sentinel sites. For this investigation, county residents evaluated for respiratory symptoms (e.g., fever, cough, or shortness of breath) who had no known risk for COVID-19 were identified at participating urgent care centers. A convenience sample of specimens that tested negative for influenza virus was tested for SARS-CoV-2 RNA. Among 226 patients who met the inclusion criteria, 23% had positive test results for influenza. Among patients who had negative test results for influenza, 79 specimens were tested for SARS-CoV-2, and 11% had evidence of infection. This sentinel surveillance system helped confirm community transmission of SARS-CoV-2 in Santa Clara County. As a result of these data and an increasing number of cases with no known source of transmission, the county initiated a series of community mitigation strategies. Detection of community transmission is critical for informing response activities, including testing criteria, quarantine guidance, investigation protocols, and community mitigation measures (2). Sentinel surveillance in outpatient settings and emergency departments, implemented together with hospital-based surveillance, mortality surveillance, and serologic surveys, can provide a robust approach to monitor the epidemiology of COVID-19.","MMWR Morb Mortal Wkly Rep","Zwald, Marissa L","Lin, Wen","Sondermeyer Cooksey, Gail L","Weiss, Charles","Suarez, Angela","Fischer, Marc","Bonin, Brandon J","Jain, Seema","Langley, Gayle E","Park, Benjamin J","Moulia, Danielle","Benedict, Rory","Nguyen, Nang","Han, George S","32271724"],"abstract":["On February 27, 2020, the Santa Clara County Public Health Department (SCCPHD) identified its first case of coronavirus disease 2019 (COVID-19) associated with probable community transmission (i.e., infection among persons without a known exposure by travel or close contact with a patient with confirmed COVID-19). At the time the investigation began, testing guidance recommended focusing on persons with clinical findings of lower respiratory illness and travel to an affected area or an epidemiologic link to a laboratory-confirmed COVID-19 case, or on persons hospitalized for severe respiratory disease and no alternative diagnosis (1). To rapidly understand the extent of COVID-19 in the community, SCCPHD, the California Department of Public Health (CDPH), and CDC began sentinel surveillance in Santa Clara County. During March 5-14, 2020, four urgent care centers in Santa Clara County participated as sentinel sites. For this investigation, county residents evaluated for respiratory symptoms (e.g., fever, cough, or shortness of breath) who had no known risk for COVID-19 were identified at participating urgent care centers. A convenience sample of specimens that tested negative for influenza virus was tested for SARS-CoV-2 RNA. Among 226 patients who met the inclusion criteria, 23% had positive test results for influenza. Among patients who had negative test results for influenza, 79 specimens were tested for SARS-CoV-2, and 11% had evidence of infection. This sentinel surveillance system helped confirm community transmission of SARS-CoV-2 in Santa Clara County. As a result of these data and an increasing number of cases with no known source of transmission, the county initiated a series of community mitigation strategies. Detection of community transmission is critical for informing response activities, including testing criteria, quarantine guidance, investigation protocols, and community mitigation measures (2). Sentinel surveillance in outpatient settings and emergency departments, implemented together with hospital-based surveillance, mortality surveillance, and serologic surveys, can provide a robust approach to monitor the epidemiology of COVID-19."],"journal":"MMWR Morb Mortal Wkly Rep","authors":["Zwald, Marissa L","Lin, Wen","Sondermeyer Cooksey, Gail L","Weiss, Charles","Suarez, Angela","Fischer, Marc","Bonin, Brandon J","Jain, Seema","Langley, Gayle E","Park, Benjamin J","Moulia, Danielle","Benedict, Rory","Nguyen, Nang","Han, George S"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271724","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.15585/mmwr.mm6914e3","locations":["USA","USA","USA","California"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138491761721346,"score":248.83047},{"pmid":32379727,"title":"Improving Detection and Response to Respiratory Events - Kenya, April 2016-April 2020.","text":["Improving Detection and Response to Respiratory Events - Kenya, April 2016-April 2020.","Respiratory pathogens, such as novel influenza A viruses, Middle East respiratory syndrome coronavirus (MERS-CoV), and now, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are of particular concern because of their high transmissibility and history of global spread (1). Clusters of severe respiratory disease are challenging to investigate, especially in resource-limited settings, and disease etiology often is not well understood. In 2014, endorsed by the Group of Seven (G7),* the Global Health Security Agenda (GHSA) was established to help build country capacity to prevent, detect, and respond to infectious disease threats.(dagger) GHSA is a multinational, multisectoral collaboration to support countries towards full implementation of the World Health Organization's International Health Regulations (IHR).( section sign) Initially, 11 technical areas for collaborator participation were identified to meet GHSA goals. CDC developed the Detection and Response to Respiratory Events (DaRRE) strategy in 2014 to enhance country capacity to identify and control respiratory disease outbreaks. DaRRE initiatives support the four of 11 GHSA technical areas that CDC focuses on: surveillance, laboratory capacity, emergency operations, and workforce development.( paragraph sign) In 2016, Kenya was selected to pilot DaRRE because of its existing respiratory disease surveillance and laboratory platforms and well-developed Field Epidemiology and Laboratory Training Program (FELTP) (2). During 2016-2020, Kenya's DaRRE partners (CDC, the Kenya Ministry of Health [MoH], and Kenya's county public health officials) conceptualized, planned, and implemented key components of DaRRE. Activities were selected based on existing capacity and determined by the Kenya MoH and included 1) expansion of severe acute respiratory illness (SARI) surveillance sites; 2) piloting of community event-based surveillance; 3) expansion of laboratory diagnostic capacity; 4) training of public health practitioners in detection, investigation, and response to respiratory threats; and 5) improvement of response capacity by the national emergency operations center (EOC). Progress on DaRRE activity implementation was assessed throughout the process. This pilot in Kenya demonstrated that DaRRE can support IHR requirements and can capitalize on a country's existing resources by tailoring tools to improve public health preparedness based on countries' needs.","MMWR Morb Mortal Wkly Rep","Idubor, Osatohamwen I","Kobayashi, Miwako","Ndegwa, Linus","Okeyo, Mary","Galgalo, Tura","Kalani, Rosalia","Githii, Susan","Hunsperger, Elizabeth","Balajee, Arunmozhi","Verani, Jennifer R","da Gloria Carvalho, Maria","Winchell, Jonas","Van Beneden, Chris A","Widdowson, Marc-Alain","Makayotto, Lyndah","Chaves, Sandra S","32379727"],"abstract":["Respiratory pathogens, such as novel influenza A viruses, Middle East respiratory syndrome coronavirus (MERS-CoV), and now, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are of particular concern because of their high transmissibility and history of global spread (1). Clusters of severe respiratory disease are challenging to investigate, especially in resource-limited settings, and disease etiology often is not well understood. In 2014, endorsed by the Group of Seven (G7),* the Global Health Security Agenda (GHSA) was established to help build country capacity to prevent, detect, and respond to infectious disease threats.(dagger) GHSA is a multinational, multisectoral collaboration to support countries towards full implementation of the World Health Organization's International Health Regulations (IHR).( section sign) Initially, 11 technical areas for collaborator participation were identified to meet GHSA goals. CDC developed the Detection and Response to Respiratory Events (DaRRE) strategy in 2014 to enhance country capacity to identify and control respiratory disease outbreaks. DaRRE initiatives support the four of 11 GHSA technical areas that CDC focuses on: surveillance, laboratory capacity, emergency operations, and workforce development.( paragraph sign) In 2016, Kenya was selected to pilot DaRRE because of its existing respiratory disease surveillance and laboratory platforms and well-developed Field Epidemiology and Laboratory Training Program (FELTP) (2). During 2016-2020, Kenya's DaRRE partners (CDC, the Kenya Ministry of Health [MoH], and Kenya's county public health officials) conceptualized, planned, and implemented key components of DaRRE. Activities were selected based on existing capacity and determined by the Kenya MoH and included 1) expansion of severe acute respiratory illness (SARI) surveillance sites; 2) piloting of community event-based surveillance; 3) expansion of laboratory diagnostic capacity; 4) training of public health practitioners in detection, investigation, and response to respiratory threats; and 5) improvement of response capacity by the national emergency operations center (EOC). Progress on DaRRE activity implementation was assessed throughout the process. This pilot in Kenya demonstrated that DaRRE can support IHR requirements and can capitalize on a country's existing resources by tailoring tools to improve public health preparedness based on countries' needs."],"journal":"MMWR Morb Mortal Wkly Rep","authors":["Idubor, Osatohamwen I","Kobayashi, Miwako","Ndegwa, Linus","Okeyo, Mary","Galgalo, Tura","Kalani, Rosalia","Githii, Susan","Hunsperger, Elizabeth","Balajee, Arunmozhi","Verani, Jennifer R","da Gloria Carvalho, Maria","Winchell, Jonas","Van Beneden, Chris A","Widdowson, Marc-Alain","Makayotto, Lyndah","Chaves, Sandra S"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379727","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.15585/mmwr.mm6918a2","locations":["Kenya","Kenya","Kenya","Kenya"],"countries":["Kenya"],"countries_codes":["KEN|Kenya"],"topics":["Prevention"],"weight":1,"_version_":1666262687670075392,"score":232.97672}]}